27 April 2022 - NICE has published evidence-based recommendations on the use of venetoclax in combination with low dose cytosine ...
20 April 2022 - This is the first appraisal of nivolumab to be terminated by NICE. ...
14 April 2022 - An innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced ...
7 April 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
13 April 2022 - Patients with relapsing-remitting multiple sclerosis in England, Wales and Northern Ireland can now access treatment with ...
13 April 2022 - NICE has published evidence based recommendations on the use of daratumumab (Darzalex) for the treatment of ...
9 April 2022 - Thousands of patients with COVID-19 who are most likely to be admitted to hospital are receiving ...
12 April 2022 - Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be ...
8 April 2022 - A rare multiple technology assessment from NICE. ...
8 April 2022 - NICE has recommended AstraZeneca and MSD’s Koselugo (selumetinib) for use by the NHS in England, within ...
7 April 2022 - NICE has today issued draft guidance which does not recommend sacituzumab govitecan for treating locally advanced or ...
7 April 2022 - Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new ...
1 April 2022 - Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture ...
30 March 2022 - Tagraxofusp is human interleukin-3 genetically conjugated to diphtheria toxin protein. ...
23 March 2022 - Over the past two years there has been an unprecedented increase in medical research, the NHS has ...